The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14784 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Reema Kashif und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology-Oncology & BMT, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Anemia, Aplastic, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The goal of this study was to assess the effect of donor type and pre‐transplant immunotherapy (IST) on outcomes of hematopoietic stem cell transplantation (HSCT) for children and young adults with severe aplastic anemia (SAA).
Methods
This retrospective, multi‐center study included 52 SAA patients, treated in 5 pediatric transplant programs in Florida, who received HSCT between 2010 and 2020 as the first‐ or second‐line treatment.
Results
The median age at HSCT for all 52 patients was 15 years (range 1–25). The 3‐year overall survival (OS) by donor type were as follows: 95% [95% CI 85.4–99] for matched related donors (MRD) ( N = 24), 84% [95% CI 63.5–99] for haploidentical ( N = 13), and 71% [95% CI 36–99] for matched unrelated donors (MUD) ( N = 7). The 3‐year OS was 81% [95% CI 69.7‐99] for all patients, 90.5% [95% CI 79.5‐99] for non‐IST patients ( N = 27), and 70% [95% CI 51–99] for IST patients ( N = 24) (log‐rank p = .04). Survival of haploidentical HSCT (haplo‐HSCT) recipients with post‐transplant cyclophosphamide (PTCy) ( N = 13) was excellent for both groups: 100% for non‐IST patients ( N = 3) and 80% for IST patients ( N = 10). The 3‐year OS for patients with previous IST by donor type in groups where >5 patients were available was 78.8% [95% CI 52.3–99] for haplo‐HSCT ( N = 10) and 66.7% [95% CI 28.7–99] for MUD ( N = 6). Although it appears that patients receiving HSCT ≥6 months after the start of IST had worse survival, the number of patients in each category was small and log‐rank was not significant( p = .65).
Conclusions
Patients receiving MUD and haplo‐HSCT with PTCy had similar outcomes, suggesting that haplo‐HSCT with PTCy could be included in randomized trials of upfront IST versus alternative donor HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology-Oncology & BMT, University of Florida, Gainesville, Florida, USA.
- Nemours Children's Health & Wolfson Children's Hospital, Jacksonville, Florida, USA.
- Center for Cell & Gene Therapy for Non-Malignant Conditions, John Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
- Pediatric Blood & Marrow Transplantation Program, Nicklaus Children's Hospital, Miami, Florida, USA.
- School of Medicine, University of Miami, Miami, Florida, USA.
ORCID-Profile: Reema Kashif, Warren Alperstein, John Ligon, Deepak Chellapandian
Zitieren
APA
Kashif, R., Horn, B., Milner, J., Joyce, M., Dalal, M., Lee, J. J., McNerney, K., Cline, J., Fort, J., Castillo, P., Galvez, J., Alperstein, W., Ligon, J., Ziga, E., Crawford, D., & Chellapandian, D. (2024). The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia. Pediatric Transplantation. https://doi.org/10.1111/petr.14784
Vancouver
Kashif R, Horn B, Milner J, Joyce M, Dalal M, Lee JJ, et al. The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia. Pediatric Transplantation. 2024. doi:10.1111/petr.14784
BibTeX
@article{Kashif2024,
author = {Kashif, Reema and Horn, Biljana and Milner, Jordan and Joyce, Michael and Dalal, Mansi and Lee, Jin-Ju and McNerney, Kevin and Cline, Jessica and Fort, John and Castillo, Paul and Galvez, Jorge and Alperstein, Warren and Ligon, John and Ziga, Edward and Crawford, David and Chellapandian, Deepak},
title = {The role of donor type and pre‐transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14784}
}
EUVIMED